Skip to main content
. 2020 Jul 21;2020:3168253. doi: 10.1155/2020/3168253

Table 2.

Comparison of the mean MD, ECD, and number of topical antiglaucoma agents.

  Preoperative (p value∗) 6 months† (p value∗) 12 months† (p value∗) 24 months† (p value∗)
MD, dB −23.6 ± 5.3
(N/A)		 −24.7 ± 5.2
(0.060)		 −24.1 ± 5.2
(0.405)		 −24.5 ± 4.9
(0.155)
ECD, cell/mm2 2149 ± 479
(N/A)		 2097 ± 457
(0.058)		 2112 ± 416
(0.125)		 2084 ± 465
(0.055)
Antiglaucoma agents 3.9 ± 0.6
(N/A)		 0.7 ± 0.5
(<0.001)		 0.9 ± 0.8
(<0.001)		 1.1 ± 0.6
(<0.001)

Values are presented as the mean ± standard deviation unless otherwise indicated (p value). MD = mean deviation; ECD = corneal endothelial cell density; N/A = not applicable. ∗Paired t-test; statistical significance: p < 0.05 vs. preoperative value. †Follow-up period after glaucoma device implantation.